Heron Therapeutics, Inc. /De/ (HRTX)

CIK 818033 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Heron Therapeutics, Inc. /De/.

Recent SEC filings

FiledFormAccession number
Aug 14, 20268-K0001193125-26-352403
Aug 10, 202640001193125-26-341528
Aug 10, 20268-K0001193125-26-341300
Aug 10, 202610-Q0001193125-26-341301
Aug 3, 202640001193125-26-329720
Aug 3, 202640001193125-26-329694
Aug 3, 202640001193125-26-329804
Aug 3, 202640001193125-26-329848
Jul 20, 202640001193125-26-308958
Jul 20, 202640001193125-26-308887
Jul 20, 202640001193125-26-308922
Jun 25, 20268-K0001193125-26-282988
Jun 17, 202640001193125-26-273552
Jun 16, 20268-K0001193125-26-272388
Jun 8, 202640001193125-26-260931
Jun 2, 20268-K0001193125-26-253851
May 13, 2026SCHEDULE 13G/A0000919574-26-002913
May 11, 20268-K0001193125-26-215752
May 11, 202610-Q0001193125-26-215755
May 7, 202640001193125-26-211230
May 4, 202640001193125-26-203344
May 4, 202640001193125-26-203196
May 4, 202640001193125-26-203374
May 4, 202640001193125-26-203272
Apr 30, 2026ARS0001193125-26-196314